• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《化脓性汗腺炎的最新临床治疗进展与新兴疗法》

An Update on Current Clinical Management and Emerging Treatments in Hidradenitis Suppurativa.

机构信息

University of Central Florida/HCA Consortium, Tallahassee, FL, USA.

Dermatology Associates of Tallahassee, Tallahassee, FL, USA.

出版信息

Skin Therapy Lett. 2024 Mar;29(2):1-6.

PMID:38574201
Abstract

Hidradenitis suppurativa (HS) is a severe, debilitating, chronic inflammatory skin disease characterized by recurrent painful nodules, abscesses and draining sinus tracts in intertriginous areas. While this condition appears to stem from follicular unit dysfunction, its cause is multifactorial and the exact pathogenesis has yet to be fully elucidated. These factors make treatment selection challenging and contribute to variable therapeutic response among affected patients. Typical regimens consist of a combination of medical and surgical modalities, tailored to individual responses. However, HS is often refractory to traditional treatments, prompting the need for newer and more effective therapies. Herein, we review current and emerging HS therapies.

摘要

化脓性汗腺炎(HS)是一种严重的、使人虚弱的、慢性炎症性皮肤病,其特征是反复发作的疼痛性结节、脓肿和在皱褶部位有渗出窦道。虽然这种情况似乎源于毛囊单位功能障碍,但它的病因是多因素的,确切的发病机制尚未完全阐明。这些因素使得治疗选择具有挑战性,并导致受影响患者之间的治疗反应存在差异。典型的方案包括针对个体反应的医疗和手术方式的组合。然而,HS 通常对传统治疗方法有抗药性,因此需要新的、更有效的治疗方法。在此,我们综述了目前和新兴的 HS 治疗方法。

相似文献

1
An Update on Current Clinical Management and Emerging Treatments in Hidradenitis Suppurativa.《化脓性汗腺炎的最新临床治疗进展与新兴疗法》
Skin Therapy Lett. 2024 Mar;29(2):1-6.
2
Treatment of severe hidradenitis suppurativa with a combination of 5-aminolevulinic acid photodynamic therapy, surgery, and secukinumab.联合 5-氨基酮戊酸光动力疗法、手术和司库奇尤单抗治疗重度化脓性汗腺炎。
Photodiagnosis Photodyn Ther. 2023 Jun;42:103637. doi: 10.1016/j.pdpdt.2023.103637. Epub 2023 Jun 1.
3
Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.皮肤科和性病科在莫斯塔尔临床医院用阿达木单抗治疗两例化脓性汗腺炎。
Acta Dermatovenerol Croat. 2021 Jul;29(2):108-110.
4
Bimekizumab for the treatment of hidradenitis suppurativa.比美吉珠单抗治疗化脓性汗腺炎。
Immunotherapy. 2024;16(16-17):1005-1013. doi: 10.1080/1750743X.2024.2401308. Epub 2024 Sep 19.
5
New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa.深入了解化脓性汗腺炎的分子发病机制和免疫调节治疗。
Int J Mol Sci. 2023 May 8;24(9):8428. doi: 10.3390/ijms24098428.
6
Medical Management of Hidradenitis Suppurativa with Non-Biologic Therapy: What's New?非生物疗法治疗化脓性汗腺炎的医学管理:有哪些新进展?
Am J Clin Dermatol. 2022 Mar;23(2):167-176. doi: 10.1007/s40257-021-00667-8. Epub 2022 Jan 6.
7
Pharmacological development in hidradenitis suppurativa.化脓性汗腺炎的药物研发。
Curr Opin Pharmacol. 2019 Jun;46:65-72. doi: 10.1016/j.coph.2019.04.006. Epub 2019 May 7.
8
Hidradenitis suppurativa: a review of current treatment options.化脓性汗腺炎:当前治疗选择综述
Int J Dermatol. 2022 Sep;61(9):1152-1164. doi: 10.1111/ijd.16115. Epub 2022 Feb 6.
9
Novel Therapeutic Approaches and Targets for the Treatment of Hidradenitis Suppurativa.用于治疗化脓性汗腺炎的新型治疗方法和靶点。
Curr Pharm Biotechnol. 2021;22(1):59-72. doi: 10.2174/1389201021666200505100556.
10
Surgical deroofing in pediatric patients with hidradenitis suppurativa.小儿化脓性汗腺炎的外科去顶术。
Pediatr Dermatol. 2022 May;39(3):502-505. doi: 10.1111/pde.14955. Epub 2022 Feb 17.

引用本文的文献

1
Management and Burden of Hidradenitis Suppurativa: An Italian Hybrid Real-World Study.化脓性汗腺炎的管理与负担:一项意大利混合现实世界研究。
Dermatol Ther (Heidelb). 2025 May 9. doi: 10.1007/s13555-025-01407-0.
2
Neutrophil Extracellular Traps Are Widely Distributed Across Lesional and Perilesional Hidradenitis Suppurativa Skin, and Elevated Serum NET Markers Associate With Moderate to Severe HS Disease.中性粒细胞胞外诱捕网广泛分布于化脓性汗腺炎的皮损及皮损周围皮肤,血清中NET标志物升高与中度至重度化脓性汗腺炎疾病相关。
Int J Dermatol. 2025 Jul;64(7):1234-1241. doi: 10.1111/ijd.17706. Epub 2025 Mar 13.
3
Hidradenitis suppurativa, from basic science to surgery and a new era of tailored targeted therapy: An expert opinion paper.
化脓性汗腺炎:从基础科学到外科手术及量身定制的靶向治疗新时代:一篇专家意见论文
Arch Dermatol Res. 2025 Feb 28;317(1):511. doi: 10.1007/s00403-025-04016-1.